Compound: Convallatoxin
SMILES: O=C1OCC(=C1)[C@@H]2[C@@]3([C@@](O)([C@H]4[C@@H]([C@]5(C=O)[C@@](O)(C[C@@H](O[C@@H]6O[C@H]([C@H](O)[C@H]([C@H]6O)O)C)CC5)CC4)CC3)CC2)C
InChIKey: HULMNSIAKWANQO-JQKSAQOKSA-N
Synonyms: Convallatoxin, 508-75-8, Corglycone, Convallotoxin, Convallaton, Corglykon, Korglykon, Convallaotoxin, Corglycon, Convallatoxoside, Strophanthidin 3-O-alpha-L-rhamnoside, Strophanthidin, 3-(6-deoxy-alpha-L-mannopyranoside), JY264VIR1Y, CHEBI:27663, Strophanthidin alpha-L-rhamnoside, DTXSID90862073, Rhamnoside, strophanthidin-3, alpha-L-, 3beta-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-5,14-dihydroxy-19-oxo-5beta-card-20(22)-enolide, 3beta-(6-deoxy-alpha-L-mannopyranosyloxy)-5,14-dihydroxy-19-oxo-5beta-card-20(22)-enolide, Mannopyranoside, strophanthidin-3,6-deoxy-, alpha-L-, NSC-407808, (3S,5S,8R,9S,10S,13R,14S,17R)-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde, Card-20(22)-enolide, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-5,14-dihydroxy-19-oxo-, (3beta,5beta)-, korglycon, (3beta,5beta)-3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-5,14-dihydroxy-19-oxo-card-20(22)-enolide, strophanthidin-alpha-L-rhamnoside, 5beta,14beta-Dihydroxy-19-oxo-3beta((alpha-L-rhamnopyranosyl)oxy)card-20,22-enolide, 5beta,14beta-Dihydroxy-19-oxo-3beta[(alpha-L-rhamnopyranosyl)oxy]card-20,22-enolide, (3S,5S,8R,9S,10S,13R,14S,17R)-5,14-Dihydroxy-13-methyl-17-(5-oxo-2,5-dihydrofuran-3-yl)-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)hexadecahydro-1H-cyclopenta(a)phenanthrene-10-carbaldehyde, (3S,5S,8R,9S,10S,13R,14S,17R)-5,14-dihydroxy-13-methyl-17-(5-oxo-2,5-dihydrofuran-3-yl)-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)hexadecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde, (3S,5S,8R,9S,10S,13R,14S,17R)-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl)oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthrene-10-carbaldehyde, 3beta-[(6-Deoxy-alpha-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxo-5beta-card-20(22)-enolide, RefChem:127822, DTXCID701474958, (1S,2S,5S,7S,10R,11S,14R,15R)-7,11-dihydroxy-15-methyl-14-(5-oxo-2,5-dihydrofuran-3-yl)-5-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl)oxy)tetracyclo(8.7.0.02,7.011,15)heptadecane-2-carbaldehyde, 208-086-3, (3S,5S,8R,9S,10S,13R,14S,17R)-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde, UNII-JY264VIR1Y, HSDB 3475, HULMNSIAKWANQO-JQKSAQOKSA-N, EINECS 208-086-3, C29H42O10, NSC 407808, Convallatoxin (Standard), Convallatoxin, >=65%, CONVALLATOXIN [MI], SCHEMBL308440, CONVALLATOXIN [WHO-DD], CHEMBL399336, orb1297411, orb3139303, HY-N2453R, HY-N2453, BDBM50480587, LMST01120013, MFCD00069477, MSK162606, AKOS040760350, EBC-615646, (1R,3aS,3bR,5aS,7S,9aS,9bS,11aR)-3a,5a-dihydroxy-11a-methyl-1-(5-oxo-2,5-dihydrofuran-3-yl)-7-{[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-hexadecahydro-1H-cyclopenta[a]phenanthrene-9a-carbaldehyde, AC-35137, FC137904, MS-30077, STROPHANTHIDIN .ALPHA.-L-RHAMNOSIDE, CS-0022681, NS00005101, C08858, Q2996215, 3beta-(alpha-L-rhamnopyranosyloxy)-5,14-dihydroxy-19-oxo-5beta-card-20(22)-enolide, Card-20(22)-enolide, 3-[(6-deoxyhexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, CARD-20(22)-ENOLIDE, 3-((6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)OXY)-5,14-DIHYDROXY-19-OXO-, (3.BETA.,5.BETA.)-
Theoretical properties:
Physical properties:
Descriptions:
chebi: A cardenolide glycoside that consists of strophanthidin having a 6-deoxy-α-<small>L</small>-mannopyranosyl (<small>L</small>-rhamnosyl) group attached at position 3.
chembl: CONVALLATOXIN is a small molecule listed in the ChEMBL database but has not progressed to an approved clinical phase.
wikipedia: Convallatoxin is a glycoside extracted from Convallaria majalis.